Inhibitory effects of ketamine on lipopolysaccharide-induced microglial activation. - Wikidata - awgldk - TriplyDB

Inhibitory effects of ketamine on lipopolysaccharide-induced microglial activation.

Inhibitory effects of ketamine on lipopolysaccharide-induced microglial activation.

http://www.wikidata.org/entity/Q37143323

about

Neuroplasticity and the next wave of antidepressant strategies Minocycline: therapeutic potential in psychiatry The role of the surface on microglia function: implications for central nervous system tissue engineering Ketamine influences CLOCK:BMAL1 function leading to altered circadian gene expression The role of the JAK2-STAT3 pathway in pro-inflammatory responses of EMF-stimulated N9 microglial cells.Microglial dysregulation in psychiatric disease Kinin B1 receptors mediate depression-like behavior response in stressed mice treated with systemic E. coli lipopolysaccharide.General anesthetics inhibit LPS-induced IL-1β expression in glial cells.Modulation of microglial function by the antidepressant drug venlafaxine Effects of ketamine on endotoxin and traumatic brain injury induced cytokine production in the rat.Duality of Antidepressants and Neuroprotectants.Neuroinflammation, neurodegeneration, and depression.The emerging use of ketamine for anesthesia and sedation in traumatic brain injuries.Ketamine and peripheral inflammation.Integrating neuroimmune systems in the neurobiology of depression.Biological hypotheses and biomarkers of bipolar disorder.Ketamine inhibits calcium elevation and hydroxyl radical and nitric oxide production in lipopolysaccharide-stimulated NR8383 alveolar macrophages.Ketamine, a Clinically Used Anesthetic, Inhibits Vascular Smooth Muscle Cell Proliferation via PP2A-Activated PI3K/Akt/ERK Inhibition.Ketamine depresses toll-like receptor 3 signaling in spinal microglia in a rat model of neuropathic pain.Autophagy in Traumatic Brain Injury: A New Target for Therapeutic Intervention.Nicorandil reverses the behavioral changes and brain oxidative stress in a model of schizophrenia induced by ketamine in mice Effect of ketamine on oxidative stress following lipopolysaccharide administration

P2860

Q21129480-269C00C6-DC3C-4602-ABF1-59A5917C7232 Q22241418-116C2572-9D52-4FB8-82AC-BF15AAF4DB28 Q28386483-450A4557-221A-4A57-80CB-965363A96A35 Q28476686-EA915CF1-CDEE-44D3-8482-4BD033405D4A Q34154283-21A3FC2E-935A-46B4-BE27-DFAF616821D2 Q34345744-12E92D64-64A0-43DC-9DB4-5B2E8090BCB0 Q34499830-6023802A-C0CE-4D8C-AF70-DD5E84FA9B60 Q35070648-41E0A343-0042-4E6E-87A6-3C9049ACF035 Q35620478-954CF011-1477-4CE4-B306-FE29C80BB75C Q36107372-495F0825-A159-47C4-BFF4-5BB3C36B8799 Q36944840-C294B509-F94C-4E78-A18A-11B577F2EA50 Q37116106-D89694FE-CE2B-44DF-8AAE-B8D10D4D5FCB Q38088382-31BB1BBB-1176-4627-BEC7-E8261483DD54 Q38097975-ED4373FC-F4E1-4628-91CC-F1C9B1CB0990 Q38859380-DA22F69E-E035-4550-81CB-71E83D3D560D Q38995726-FA10A682-BFC5-4FF7-943A-F904EFC90F31 Q39164335-A236F327-1EDE-4CE6-B0CA-E9E13EB18846 Q47226338-9BDF080C-A238-461D-AE7C-47B882542956 Q48280646-7BA43AE3-20D6-438E-8E82-E219C44D3C5F Q55228013-2E045A22-8E65-4DB8-B3ED-3024B4D5788F Q57729831-FF978D9C-1212-4728-8AB6-D688BC386CAC Q57729902-07FDDC92-A90A-4CC7-A9B0-F39E537F2E7C

P2860

Inhibitory effects of ketamine on lipopolysaccharide-induced microglial activation.

http://www.wikidata.org/entity/Q37143323

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 30 March 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Inhibitory effects of ketamine on lipopolysaccharide-induced microglial activation.

@en

Inhibitory effects of ketamine on lipopolysaccharide-induced microglial activation.

@nl

type

label

Inhibitory effects of ketamine on lipopolysaccharide-induced microglial activation.

@en

Inhibitory effects of ketamine on lipopolysaccharide-induced microglial activation.

@nl

prefLabel

Inhibitory effects of ketamine on lipopolysaccharide-induced microglial activation.

@en

Inhibitory effects of ketamine on lipopolysaccharide-induced microglial activation.

@nl

P1433

Q37143323-79D6A594-C360-4EDE-94EE-04B1434D1323

P1476

Q37143323-78A8BE8B-901D-4BFF-A3CF-ACC2AFFB8DA7

P2093

Q37143323-05D3F354-0256-44EE-B2FF-4EC39B3197EA

Q37143323-14DAB823-42C1-40D6-BCAA-D1FA1E259A3D

Q37143323-18D14D14-1C2E-458E-A680-6AE3B11A4CCE

Q37143323-216EB542-F8A5-41C9-9BFA-92496BE3BCE9

Q37143323-59DE5DEA-B966-4527-BAF4-CEC71D5B703F

Q37143323-FB47B7E4-11F7-4B87-BB8E-4F9BE2CCAFBF

P2860

Q37143323-1D687EAF-24B5-4F49-B968-24CECE2B73BC

Q37143323-254EA922-1A93-49A5-B8B5-8A76BA57A536

Q37143323-2D9368BF-B6D7-4420-8FD3-753EDA096BD7

Q37143323-406EECA2-AEE7-44C2-835B-5AB230EF01DC

Q37143323-4544B3B4-E739-42B0-8929-2AA9DF456FB5

Q37143323-66004FC9-699D-4D7D-A3DB-A1B1D26A6796

Q37143323-66048215-3BCB-4989-A813-DCDF3576083F

Q37143323-6925FC36-6101-4A6C-8095-5D08EC60461C

Q37143323-6FD3B565-1537-47F3-9391-FBCBAB79C7B0

Q37143323-7586CCBA-268B-44A8-AD09-2F77EC0F0910

P304

Q37143323-3DED413A-AF6B-435F-86CD-78155ABB6377

P31

Q37143323-A985F86E-8CFA-477F-8772-C5664CC2613C

P356

Q37143323-79667FD0-1CF0-41FF-A86D-DD0011C1D63E

P478

Q37143323-FE3974E5-E7E9-416D-A3DC-00CA583878DA

P577

Q37143323-BB5D74F1-2DD8-4485-9BEC-DB5D741F1FC2

P5875

Q37143323-F764E9B8-4D34-4FD3-A690-5BE9FD6A7984

P698

Q37143323-EE62E3C1-D4C4-49AB-91D4-986FBBAF99C6

P921

Q37143323-13669232-EA14-489B-9220-99C8D82F044F

Q37143323-D81FD137-2A79-4045-B35D-A030D999664B

P932

Q37143323-27B7EE56-BEC6-4DEC-A070-EAAB837D0F2F

P356

P1433

Mediators of Inflammation

P1476

Inhibitory effects of ketamine on lipopolysaccharide-induced microglial activation.

@en

P2093

Cheng-Ying Hsieh

http://www.w3.org/2001/XMLSchema#string

Duen-Suey Chou

http://www.w3.org/2001/XMLSchema#string

George Hsiao

http://www.w3.org/2001/XMLSchema#string

Jie-Jen Lee

http://www.w3.org/2001/XMLSchema#string

Joen-Rong Sheu

http://www.w3.org/2001/XMLSchema#string

Yi Chang

http://www.w3.org/2001/XMLSchema#string

P2860

Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays

Reduction in lipopolysaccharide-induced thrombocytopenia by triflavin in a rat model of septicemia.

Microglia as mediators of inflammatory and degenerative diseases.

IL-1-regulated responses in astrocytes: relevance to injury and recovery.

Microglia as neuroprotective, immunocompetent cells of the CNS.

The role of glial reaction and inflammation in Parkinson's disease.

Microglia, major player in the brain inflammation: their roles in the pathogenesis of Parkinson's disease.

Something new about ketamine for pediatric anesthesia?

The pathogenesis of sepsis.

Activated microglia mediate neuronal cell injury via a nitric oxide mechanism.

P304

705379

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2009/705379

http://www.w3.org/2001/XMLSchema#string

P478

2009

http://www.w3.org/2001/XMLSchema#string

P577

2009-03-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

24254691

http://www.w3.org/2001/XMLSchema#string

P698

19343193

http://www.w3.org/2001/XMLSchema#string

P921

lipopolysaccharide

P932

2662525

http://www.w3.org/2001/XMLSchema#string